312 related articles for article (PubMed ID: 15007876)
21. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1999)].
Shimada K; Nakano K; Ohno I; Okada S; Hayashi K; Yokouchi H; Arakawa M; Gejyo F; Igarashi K; Ikemoto H; Mori T; Okada M; Ozaki K; Igari J; Aoki N; Oguri T; Kitamura N; Terai T; Suzuki Y; Inoue H; Nakadate T; Karasawa Y; Ito C; Yoshida T; Nakata K; Nakatani T; Inagawa H; Ando M; Suga M; Sato K; Kudo K; Kobayashi N; Tosaka M; Hasegawa M; Kohno S; Tomono K; Miyazaki Y; Kobayashi H; Kawai S; Takayasu S; Hirakata Y; Matsuda J; Mochida C; Ito A; Sumitomo M; Nasu M; Nagai H; Matsushima T; Niki Y; Hiramatsu K; Nakano T
Jpn J Antibiot; 2001 Jul; 54(7):331-64. PubMed ID: 11560054
[TBL] [Abstract][Full Text] [Related]
22. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1993)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N
Jpn J Antibiot; 1996 Feb; 49(2):107-43. PubMed ID: 8721076
[TBL] [Abstract][Full Text] [Related]
23. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1992)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N
Jpn J Antibiot; 1996 Jan; 49(1):34-70. PubMed ID: 8851305
[TBL] [Abstract][Full Text] [Related]
24. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
[TBL] [Abstract][Full Text] [Related]
25. [Antibacterial activity of panipenem against clinical isolates in 2000 and 2001].
Abe T; Fukuoka T; Sato Y; Ito K; Sei M
Jpn J Antibiot; 2002 Dec; 55(6):808-26. PubMed ID: 12621735
[TBL] [Abstract][Full Text] [Related]
26. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Fujime M; Fujita K; Shigeta S; Watanabe J; Igari J; Ogiwara M; Ishibashi K; Oguri T; Yoshida H; Imafuku Y; Yamaguchi K; Matsumoto T; Kashitani F; Murai M; Ooe H; Nishikawa M; Watanabe K; Kobayashi Y; Uchida H; Oka T; Mochida C
Jpn J Antibiot; 1999 Feb; 52(2):93-129. PubMed ID: 10221177
[TBL] [Abstract][Full Text] [Related]
27. [Antimicrobial activities of beta-lactam antibiotics against clinically isolated Haemophilus influenzae].
Takahashi T; Tsujihara Y; Harada M; Shimura H; Takahashi S; Hachiya K; Matsumoto F; Takahashi S
Jpn J Antibiot; 1999 Apr; 52(4):292-301. PubMed ID: 10396686
[TBL] [Abstract][Full Text] [Related]
28. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1990). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1995 Oct; 48(10):1295-316. PubMed ID: 8544334
[TBL] [Abstract][Full Text] [Related]
29. [Bacteriological, pharmacokinetic and clinical studies of cefditoren pivoxil in the pediatric field].
Toyonaga Y; Ishihara T; Sano T; Tezuka T; Nakamura H
Jpn J Antibiot; 1993 Jul; 46(7):604-28. PubMed ID: 8371496
[TBL] [Abstract][Full Text] [Related]
30. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
Yang Q; Xu Y; Chen M; Wang H; Sun H; Hu Y; Zhang R; Duan Q; Zhuo C; Cao B; Liu Y; Yu Y; Sun Z; Chu Y
Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692
[TBL] [Abstract][Full Text] [Related]
31. [In vitro and in vivo activities of cefpodoxime proxetil against penicillin-resistant Streptococcus pneumoniae].
Kawada H; Kitayama A; Fukuoka T; Ishii C; Abe T; Kakuta M; Domon H; Ohya S; Utsui Y
Jpn J Antibiot; 1999 Aug; 52(8):533-40. PubMed ID: 10587878
[TBL] [Abstract][Full Text] [Related]
32. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1991). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1995 Oct; 48(10):1394-421. PubMed ID: 8544337
[TBL] [Abstract][Full Text] [Related]
33. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1998)].
Ikemoto H; Arakawa M; Gejyo F; Igarashi K; Mori T; Okada M; Ozaki K; Igari J; Aoki N; Oguri T; Kitamura N; Terai T; Sekine O; Suzuki Y; Inoue H; Nakadate T; Karasawa Y; Ito C; Yoshida T; Nakata K; Nakatani T; Ohno I; Okada S; Inagawa H; Kudo K; Kobayashi N; Ando M; Suga M; Sato K; Kondo T; Tosaka M; Kobayashi H; Kawai S; Takayasu S; Kohno S; Tomono K; Shimada K; Nakano K; Miyazaki Y; Izumikawa K; Yamaguchi T; Mochida C; Yokouchi H; Ito A; Sumitomo M; Nasu M; Nagai H; Yamasaki T; Matsushima T; Nakano T
Jpn J Antibiot; 2000 May; 53(5):261-98. PubMed ID: 10923284
[TBL] [Abstract][Full Text] [Related]
34. [Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1982). I. Susceptibility distribution].
Kosakai N; Igari J; Kumamoto Y; Sakai S; Nishio A; Nagai T; Shigeta S; Shiraiwa Y; Abe K; Tazaki H
Jpn J Antibiot; 1984 Apr; 37(4):680-722. PubMed ID: 6433064
[TBL] [Abstract][Full Text] [Related]
35. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333
[TBL] [Abstract][Full Text] [Related]
36. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1986). I. Susceptibility distribution].
Kosakai N; Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1989 Oct; 42(10):2141-73. PubMed ID: 2691714
[TBL] [Abstract][Full Text] [Related]
37. [Antimicrobial activity of cefteram comparison with other oral antibiotics].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Sato K
Jpn J Antibiot; 1989 May; 42(5):1216-32. PubMed ID: 2746861
[TBL] [Abstract][Full Text] [Related]
38. [Pharmacokinetic, bacteriological and clinical studies of SY5555 in the pediatric field].
Motohiro T; Handa S; Yamada S; Oki S; Yoshinaga Y; Oda K; Sakata Y; Kato H; Yamashita F; Imai S
Jpn J Antibiot; 1995 Feb; 48(2):238-60. PubMed ID: 7745814
[TBL] [Abstract][Full Text] [Related]
39. [The antimicrobial activity of cefteram against recently clinically detected and isolated strains].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y; Suzuki K
Jpn J Antibiot; 1993 Sep; 46(9):801-17. PubMed ID: 8254900
[TBL] [Abstract][Full Text] [Related]
40. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1988). I. Susceptibility distribution].
Kosakai N; Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M
Jpn J Antibiot; 1992 Sep; 45(9):1071-102. PubMed ID: 1433906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
